GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (XSWX:ERF) » Definitions » Cyclically Adjusted PS Ratio

Eurofins Scientific SE (XSWX:ERF) Cyclically Adjusted PS Ratio : (As of May. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Eurofins Scientific SE Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eurofins Scientific SE Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eurofins Scientific SE's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Cyclically Adjusted PS Ratio Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.90 4.57 5.92 3.06 2.35

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.92 - 3.06 - 2.35

Competitive Comparison of Eurofins Scientific SE's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Cyclically Adjusted PS Ratio falls into.



Eurofins Scientific SE Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eurofins Scientific SE's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Eurofins Scientific SE's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=32.201/121.1700*121.1700
=32.201

Current CPI (Dec23) = 121.1700.

Eurofins Scientific SE Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 10.560 98.830 12.947
201512 12.996 99.910 15.761
201612 16.086 101.040 19.291
201712 19.284 102.410 22.817
201812 23.316 104.320 27.082
201912 26.711 106.080 30.511
202012 30.006 106.670 34.085
202112 36.641 111.090 39.966
202212 34.718 117.060 35.937
202312 32.201 121.170 32.201

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eurofins Scientific SE  (XSWX:ERF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eurofins Scientific SE Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (XSWX:ERF) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (XSWX:ERF) Headlines

From GuruFocus

Enerplus Corporation Is a Stock to Stay Away From

By MacroConsultants MacroConsultants 04-27-2015

Why Investors Should Be Cautious About Enerplus in the Short Run

By RHPanalysts RHPanalysts 05-24-2015

ERF 8.2% Yield Put into Perspective

By Ilia Frankstein Ilia Frankstein 10-10-2011

Enerplus: Investors Need to Consider This Stock for the Long Run

By Thriftyinvestments Thriftyinvestments 05-13-2015